Mizuho Raises Cardinal Health (CAH) Price Target to $280
Key Points
- Mizuho reiterated its Outperform rating on Cardinal Health CAH on October 20, 2026, and raised its price target to $280.0 from $250.0.
- Mizuho's $280 price target implies 10.83% upside from Cardinal Health, Inc.'s ($CAH) current $252.65 share price.
- The stock recently traded around $252.65, sitting below its recent close of $255.90 on October 20, 2026.
- Cardinal Health pays an annual dividend of $2.06 per share, which gives a yield of about 0.82%.
Get Cardinal Health text alerts
We text you when insiders, Congress, analysts or big funds move on $CAH.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Cardinal Health, Inc. alert may contain errors. Disclosures
On October 20, 2026, Mizuho reiterated its Outperform rating on Cardinal Health, Inc. CAH, raising its price target to $280.0 from $250.0. According to the research note, the firm kept a positive stance on the medical distribution company. Cardinal Health closed at $255.90 on the day of the announcement.
CAH
Cardinal Health, Inc.
Mizuho vs. the S&P 500
Hypothetical returns from Mizuho's disclosed trades, not real profit or advice. How we model this.
Mizuho's Call on Cardinal Health
Mizuho's updated research note on October 20, 2026, maintained an Outperform rating on Cardinal Health CAH while lifting the price target to $280.0 from $250.0. Forward-looking analyst opinions like this one offer a view into how firms expect the company to perform.
Other Institutional Activity in Cardinal Health
WCM Investment Management, LLC grew its holdings by 105,776 shares, ending with 4,112,461 shares worth about $1,052,378,744.0 after a 2.6% increase in its report for the quarter ended June 30, 2026.
Cardinal Health, Inc. Stock Holds Steady
The stock recently traded around $252.65 as of October 20, 2026, which is down about 1.3% since it closed at $255.90 on the same day. Shares sit 7.6% above their 50-day moving average of $234.72 and 14.8% above their 200-day moving average of $220.11.
$CAH price target
Cardinal Health, Inc. daily closes and this analyst's $280 target. Not advice.
Recent Earnings
Cardinal Health reported trailing-twelve-month revenue of $254,247,993,344.0 and earnings of $7.23 per share. The company posted a net profit margin of 0.7% and year-over-year revenue growth of 5.8%. Its next earnings report is scheduled for November 5, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target raises vs 2 cuts.
-
EPS & revenue
EPS beat estimates by 12.6%. Revenue missed estimates by 2.2%.
-
Profit surprise
EBITDA missed by 27 percent. Operating income missed by 46 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
2 target raises, 2 target cuts.
-
Earnings quality
Positive free cash flow.
Earnings Call Summary
Cardinal Health reported first quarter revenue of $60.9 billion, up 22 percent year over year, with earnings per share of $3.17 beating consensus of $2.80. The company saw broad strength across all five business segments, particularly in pharmaceutical specialty solutions where profit grew 26 percent and specialty drug sales benefited from GLP-1 demand growth. The strong quarter reflected execution on strategy, successful integration of acquisitions, and robust underlying pharmaceutical utilization trends across the market.
Guidance Cardinal Health raised its full year earnings guidance to between $9.65 and $9.85 per share, up 35 cents from prior guidance. The company expects Pharma profit to grow 16 to 19 percent for the year, driven by strong drug demand and the Solaris Health acquisition closing soon. Free cash flow is now guided to $3 billion to $3.5 billion for the full year, up from prior range.
Clearly negative report. The company missed important expectations and likely triggers downward revisions.
Dividend
The company distributes an annual dividend rate of $2.06 per share, with a dividend yield of 0.82% and a payout ratio of 28.3%.
Insider Buying and Selling at Cardinal Health, Inc.
Four corporate insiders executed trades ahead of the rating update. Chief Financial Officer Aaron E. Alt sold 42,000 shares for $9,926,140.0 on August 18, 2026. Officer Jessica L. Mayer sold 29,436 shares for $6,952,485.0 on August 18, 2026. Chief Executive Officer Jason M Hollar sold 124,529 shares for $29,375,516.0 on August 19, 2026. Officer Mary C Scherer sold 2,302 shares for $546,473.0 on August 19, 2026.
Analysts Set New Price Targets
Wall Street firms have adjusted their views on the company recently. On August 13, 2026, TD Cowen maintained a Buy rating and moved its target from $275.0 to $280.0. On August 13, 2026, JP Morgan maintained a Neutral rating and lifted its target to $260.0 from $215.0. RBC Capital initiated coverage with an Outperform rating and a $276.0 target on August 19, 2026. UBS maintained a Buy rating and raised its target from $280.0 to $295.0 on October 16, 2026. Cardinal Health carries a consensus buy recommendation with a mean price target of $271.47 across 15 analyst opinions.
About Cardinal Health
Cardinal Health, Inc. operates as a healthcare services and products company, supplying customized solutions for hospitals, healthcare systems, pharmacies, and clinical laboratories through its Pharmaceutical and Specialty Solutions and Global Medical Products segments. Analyst rating updates such as Mizuho's help investors track sentiment around major distributors in the healthcare sector.
Bottom Line
Investors will look toward Cardinal Health's upcoming earnings release on November 5, 2026, for further updates on financial performance. Monitoring institutional changes and analyst adjustments provides ongoing context for the stock's market position.
Related Filing Alerts
Source: Mizuho's rating change on $CAH (Oct 20, 2026). Written by software, not financial advice. How we make alerts